UK markets closed

Keros Therapeutics, Inc. (KROS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
54.27-3.33 (-5.78%)
At close: 04:00PM EDT
54.27 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts10101110
Avg. Estimate-1.29-1.32-5.05-5.18
Low estimate-1.55-1.6-6.3-6.6
High estimate-1.1-1.1-4.41-3.72
Year ago EPS-1.27-1.33-5.2-5.05
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts8899
Avg. EstimateN/AN/A6.34M20k
Low estimateN/AN/AN/AN/A
High estimateN/AN/A30M200k
Year ago salesN/AN/A151k6.34M
Sales growth (year/est)N/AN/A4,098.70%-99.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.34-1.35-1.37-1.35
Actual EPS-1.27-1.33-1.34-1.21
Difference0.070.020.030.14
Surprise %5.20%1.50%2.20%10.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.29-1.32-5.05-5.18
7 days ago-1.34-1.37-5.27-5.47
30 days ago-1.34-1.37-5.27-5.47
60 days ago-1.33-1.36-5.15-5.6
90 days ago-1.36-1.4-5.24-5.59
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days3454
Up last 30 days3454
Down last 7 daysN/AN/AN/AN/A
Down last 30 days11N/A1
Growth estimatesKROSIndustrySector(s)S&P 500
Current qtr.-1.60%N/AN/AN/A
Next qtr.0.80%N/AN/AN/A
Current year2.90%N/AN/AN/A
Next year-2.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A